COSM
Cosmos Health Inc.
Price Chart
Latest Quote
$0.21
-0.03 (-11.92%)
Current Price
| Previous Close | $0.24 |
| Open | $0.21 |
| Day High | $0.22 |
| Day Low | $0.18 |
| Volume | 16,178,472 |
Stock Information
| Shares Outstanding | 62.08M |
| Total Debt | $17.42M |
| Cash Equivalents | $549K |
| Revenue | $69.49M |
| Net Income | $-21.13M |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Market Cap | $13.22M |
| EPS (TTM) | $-0.67 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $28.44M |
| Sales | $69.49M |
| Income | $-21.13M |
| Book/sh | $0.40 |
| Cash/sh | $0.01 |
| Employees | 163 |
Financial Ratios
| Quick Ratio | 0.63 |
| Current Ratio | 1.08 |
| Debt/Eq | 87.87 |
Returns & Margins
| ROA | -18.71% |
| ROE | -92.32% |
| Gross Margin | 10.40% |
| Operating Margin | -12.18% |
| Profit Margin | -30.41% |
Ownership
| Insider Ownership | 33.98% |
| Institutional Ownership | 5.10% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 3.04 |
| P/S | 0.19 |
| P/B | 0.53 |
Analyst Data
| Recommendation | none |
| Target Price | $4.50 |
Technical Indicators
| SMA20 | $0.24 |
| SMA50 | $0.30 |
| SMA200 | $0.54 |
| RSI | 41.83 |
| ATR | 0.0390 |
| Shares Float | 33.93M |
| Short Float | 1.98% |
| Short Ratio | 0.88 |
| Volatility | 4.12 |
| Rel Volume | 1.26 |
Performance History
| Week | +3.40% |
| Month | -24.73% |
| Quarter | -32.38% |
| 6 Months | -57.57% |
| YTD | -58.64% |
| Year | -49.29% |
| 3 Years | -93.72% |
| 5 Years | -97.16% |
| 10 Years | -96.70% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.21 | 16,618,000 |
| 2026-06-17 | $0.24 | 34,883,800 |
| 2026-06-16 | $0.25 | 36,395,900 |
| 2026-06-15 | $0.24 | 130,391,800 |
| 2026-06-12 | $0.21 | 6,141,000 |
| 2026-06-11 | $0.21 | 4,154,700 |
| 2026-06-10 | $0.23 | 8,252,200 |
| 2026-06-09 | $0.22 | 5,831,900 |
| 2026-06-08 | $0.23 | 2,444,500 |
| 2026-06-05 | $0.25 | 1,729,000 |
| 2026-06-04 | $0.27 | 2,288,400 |
| 2026-06-03 | $0.25 | 1,579,800 |
| 2026-06-02 | $0.26 | 2,517,700 |
| 2026-06-01 | $0.25 | 3,045,600 |
| 2026-05-29 | $0.25 | 775,700 |
| 2026-05-28 | $0.26 | 601,400 |
| 2026-05-27 | $0.26 | 2,221,700 |
| 2026-05-26 | $0.26 | 2,342,400 |
| 2026-05-22 | $0.25 | 403,200 |
| 2026-05-21 | $0.25 | 1,468,100 |
| 2026-05-20 | $0.28 | 627,000 |
| 2026-05-19 | $0.28 | 403,200 |
About Cosmos Health Inc.
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purÊe under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. The company was founded in 2009 and is headquartered in Thessaloniki, Greece.
đ° Latest News
Cosmos Health enters animal health market with C-Scrub brand
Proactive âĸ 2026-06-01T16:16:00Z
Insiders Who Purchased US$2.38m Of Cosmos Health Stock May Not Have Expected 15% Tumble
Simply Wall St. âĸ 2026-02-15T12:40:08Z
Cosmos Health secures $300M financing facility to launch Ethereum strategy
TipRanks âĸ 2025-08-07T13:25:51Z
A US$10m Market Cap Boost Pleasing ToCosmos Health Insiders
Simply Wall St. âĸ 2025-07-30T12:15:20Z
Cosmos Health enters U.S. market with DolCas Biotech agreement
TipRanks âĸ 2025-06-25T15:00:16Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $57,376,240 | $50,115,079 | $49,027,305 | $44,390,695 |
| Cost Of Revenue | $57,376,240 | $50,115,079 | $49,027,305 | $44,390,695 |
| Total Revenue | $65,271,815 | $54,426,402 | $53,376,874 | $50,347,652 |
| Operating Revenue | $65,271,815 | $54,426,402 | $53,376,874 | $50,347,652 |
| Expenses | ||||
| Interest Expense | $2,622,635 | $1,012,314 | $866,476 | $3,965,248 |
| Total Expenses | $81,812,634 | $69,679,252 | $75,208,091 | $57,821,688 |
| Other Income Expense | $-377,957 | $-324,303 | $3,492,180 | $-1,852,385 |
| Other Non Operating Income Expenses | $-2,170,017 | $86,737 | $-65,867 | $-2,424,649 |
| Net Non Operating Interest Income Expense | $-2,226,222 | $-605,865 | $-203,617 | $-3,728,899 |
| Interest Expense Non Operating | $2,622,635 | $1,012,314 | $866,476 | $3,965,248 |
| Operating Expense | $24,436,394 | $19,564,173 | $26,180,786 | $13,430,993 |
| Selling And Marketing Expense | $150,240 | $354,969 | $1,204,636 | $630,057 |
| General And Administrative Expense | $22,397,438 | $17,426,673 | $24,196,914 | $12,612,046 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-19,144,998 | $-16,183,018 | $-18,542,654 | $-13,830,371 |
| Net Interest Income | $-2,226,222 | $-605,865 | $-203,617 | $-3,728,899 |
| Interest Income | $396,413 | $406,449 | $662,859 | $236,349 |
| Normalized Income | $-20,937,058 | $-15,771,978 | $-22,100,701 | $-14,276,737 |
| Net Income From Continuing And Discontinued Operation | $-19,144,998 | $-16,183,018 | $-18,542,654 | $-13,830,371 |
| Total Operating Income As Reported | $-16,703,604 | $-15,544,830 | $-21,831,217 | $-7,474,036 |
| Net Income Common Stockholders | $-19,144,998 | $-22,378,042 | $-25,783,834 | $-63,945,285 |
| Net Income | $-19,144,998 | $-16,183,018 | $-18,542,654 | $-13,830,371 |
| Net Income Including Noncontrolling Interests | $-19,144,998 | $-16,183,018 | $-18,542,654 | $-13,830,371 |
| Net Income Continuous Operations | $-19,144,998 | $-16,183,018 | $-18,542,654 | $-13,830,371 |
| Pretax Income | $-19,144,998 | $-16,183,018 | $-18,542,654 | $-13,055,320 |
| Special Income Charges | $-94,175 | $-291,980 | $3,351,216 | $1,004,124 |
| Interest Income Non Operating | $396,413 | $406,449 | $662,859 | $236,349 |
| Operating Income | $-16,540,819 | $-15,252,850 | $-21,831,217 | $-7,474,036 |
| Depreciation Amortization Depletion Income Statement | $1,369,353 | $1,249,238 | $614,377 | $188,890 |
| Depreciation And Amortization In Income Statement | $1,369,353 | $1,249,238 | $614,377 | $188,890 |
| Gross Profit | $7,895,575 | $4,311,323 | $4,349,569 | $5,956,957 |
| Per Share | ||||
| Diluted EPS | $-0.63 | $-1.17 | $-2.15 | $-33.16 |
| Basic EPS | $-0.63 | $-1.17 | $-2.15 | $-33.16 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $125,898 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-16,945,070 | $-13,510,426 | $-20,619,848 | $-9,473,446 |
| Total Unusual Items | $1,792,060 | $-411,040 | $3,558,047 | $572,264 |
| Total Unusual Items Excluding Goodwill | $1,792,060 | $-411,040 | $3,558,047 | $572,264 |
| Reconciled Depreciation | $1,369,353 | $1,249,238 | $614,377 | $188,890 |
| EBITDA (Bullshit earnings) | $-15,153,010 | $-13,921,466 | $-17,061,801 | $-8,901,182 |
| EBIT | $-16,522,363 | $-15,170,704 | $-17,676,178 | $-9,090,072 |
| Diluted Average Shares | $30,289,072 | $19,147,726 | $11,968,665 | $1,928,172 |
| Basic Average Shares | $30,289,072 | $19,147,726 | $11,968,665 | $1,928,172 |
| Diluted NI Availto Com Stockholders | $-19,144,998 | $-22,378,042 | $-25,783,834 | $-63,945,285 |
| Otherunder Preferred Stock Dividend | $0 | $6,195,024 | $7,241,180 | $41,552,985 |
| Tax Provision | $0 | $0 | $0 | $775,051 |
| Other Special Charges | $-68,610 | - | $-1,910,967 | $-1,004,124 |
| Impairment Of Capital Assets | $162,785 | $291,980 | $0 | - |
| Gain On Sale Of Security | $1,886,235 | $-119,060 | $206,831 | $-431,860 |
| Research And Development | $519,363 | $533,293 | $164,859 | - |
| Selling General And Administration | $22,547,678 | $17,781,642 | $25,401,550 | $13,242,103 |
| Other Gand A | $15,619,160 | $11,733,237 | $19,642,005 | $10,183,025 |
| Salaries And Wages | $6,778,278 | $5,693,436 | $4,554,909 | $2,429,021 |
| Restructuring And Mergern Acquisition | - | $0 | $-1,440,249 | $0 |
| Preferred Stock Dividends | - | - | - | $8,561,929 |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $10,854,934 | $16,776,395 | $28,235,436 | $38,949,795 |
| Total Assets | $65,477,518 | $54,311,892 | $66,014,811 | $68,038,621 |
| Total Non Current Assets | $27,089,262 | $28,850,544 | $29,407,031 | $11,671,708 |
| Other Non Current Assets | $4,593,898 | $2,919,909 | $1,057,947 | $391,624 |
| Non Current Note Receivables | $3,146,201 | $5,774,803 | $7,049,040 | $7,643,314 |
| Goodwill And Other Intangible Assets | $7,569,695 | $7,756,534 | $7,807,592 | $706,914 |
| Other Intangible Assets | $7,519,998 | $7,706,837 | $7,757,895 | $657,217 |
| Current Assets | $38,388,256 | $25,461,347 | $36,607,780 | $56,366,913 |
| Other Current Assets | $6,543,625 | $4,889,212 | $6,252,766 | $4,943,225 |
| Restricted Cash | $2,744,219 | $0 | - | - |
| Inventory | $5,778,142 | $4,355,365 | $4,789,054 | $3,451,868 |
| Receivables | $22,560,438 | $15,880,517 | $21,712,690 | $27,207,256 |
| Loans Receivable | $487,638 | $1,171,946 | $854,338 | $804,958 |
| Accounts Receivable | $19,628,825 | $13,478,263 | $19,759,254 | $23,691,997 |
| Allowance For Doubtful Accounts Receivable | $-30,645,763 | $-22,799,219 | $-19,686,091 | $-7,309,311 |
| Gross Accounts Receivable | $50,274,588 | $36,277,482 | $39,445,345 | $31,001,308 |
| Cash Cash Equivalents And Short Term Investments | $761,832 | $336,253 | $3,853,270 | $20,764,564 |
| Cash And Cash Equivalents | $715,674 | $315,105 | $3,833,195 | $20,749,683 |
| Cash Financial | $715,674 | $315,105 | $3,833,195 | $20,749,683 |
| Non Current Deferred Assets | - | - | - | $0 |
| Non Current Deferred Taxes Assets | - | - | - | $0 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $18,654,896 | $10,795,612 | $7,427,845 | - |
| Total Debt | $19,970,012 | $11,820,716 | $12,423,952 | $12,025,027 |
| Long Term Debt And Capital Lease Obligation | $6,225,310 | $2,062,230 | $3,885,468 | $3,719,665 |
| Long Term Debt | $5,851,837 | $1,560,433 | $3,035,341 | $2,859,570 |
| Current Debt And Capital Lease Obligation | $13,744,702 | $9,758,486 | $8,538,484 | $8,305,362 |
| Current Debt | $13,518,733 | $9,550,284 | $8,225,699 | $8,040,887 |
| Other Current Borrowings | $4,329,078 | $2,554,674 | $1,584,143 | $2,271,238 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $47,052,889 | $29,778,963 | $29,971,783 | $28,381,912 |
| Total Non Current Liabilities Net Minority Interest | $8,781,045 | $4,021,423 | $5,649,313 | $6,633,058 |
| Other Non Current Liabilities | $2,555,735 | $1,959,193 | $1,763,845 | $2,913,393 |
| Current Liabilities | $38,271,844 | $25,757,540 | $24,322,470 | $21,748,854 |
| Other Current Liabilities | $7,114,169 | $3,350,173 | $3,474,096 | $2,701,584 |
| Current Notes Payable | $11,971 | $10,558 | $11,283 | $10,912 |
| Payables And Accrued Expenses | $17,412,973 | $12,648,881 | $12,309,890 | $10,741,908 |
| Interest Payable | $786,497 | $221,820 | $166,348 | $275,547 |
| Payables | $16,626,476 | $12,427,061 | $12,143,542 | $10,466,361 |
| Accounts Payable | $14,624,006 | $11,157,658 | $11,911,978 | $10,134,146 |
| Total Tax Payable | - | - | $0 | $126,855 |
| Equity | ||||
| Common Stock Equity | $18,424,629 | $24,532,929 | $36,043,028 | $39,284,295 |
| Total Equity Gross Minority Interest | $18,424,629 | $24,532,929 | $36,043,028 | $39,656,709 |
| Stockholders Equity | $18,424,629 | $24,532,929 | $36,043,028 | $39,656,709 |
| Gains Losses Not Affecting Retained Earnings | $331,503 | $-2,134,931 | $-419,844 | $-1,132,635 |
| Other Equity Adjustments | $331,503 | $-2,134,931 | $-419,844 | $-1,132,635 |
| Retained Earnings | $-133,167,273 | $-114,022,275 | $-91,644,233 | $-66,232,813 |
| Other Equity Interest | - | $-20 | $-20 | $-4,750,108 |
| Preferred Stock Equity | - | - | - | $372,414 |
| Other | ||||
| Treasury Shares Number | $86,497 | $86,497 | $86,497 | $15,497 |
| Ordinary Shares Number | $41,067,312 | $23,602,638 | $15,895,975 | $10,589,915 |
| Share Issued | $41,153,809 | $23,689,135 | $15,982,472 | $10,605,412 |
| Tangible Book Value | $10,854,934 | $16,776,395 | $28,235,436 | $38,577,381 |
| Invested Capital | $37,795,199 | $35,643,646 | $47,304,068 | $50,184,752 |
| Working Capital | $116,412 | $-296,193 | $12,285,310 | $34,618,059 |
| Capital Lease Obligations | $599,442 | $709,999 | $1,162,912 | $1,124,570 |
| Total Capitalization | $24,276,466 | $26,093,362 | $39,078,369 | $42,516,279 |
| Treasury Stock | $917,159 | $917,159 | $917,159 | $816,707 |
| Additional Paid In Capital | $152,136,404 | $141,583,625 | $129,008,301 | $112,205,952 |
| Capital Stock | $41,154 | $23,689 | $15,983 | $383,020 |
| Common Stock | $41,154 | $23,689 | $15,983 | $10,606 |
| Preferred Stock | $0 | $0 | $0 | $372,414 |
| Long Term Capital Lease Obligation | $373,473 | $501,797 | $850,127 | $860,095 |
| Current Capital Lease Obligation | $225,969 | $208,202 | $312,785 | $264,475 |
| Line Of Credit | $9,177,684 | $6,985,052 | $6,630,273 | $5,758,737 |
| Current Accrued Expenses | $786,497 | $221,820 | $166,348 | $275,547 |
| Dueto Related Parties Current | $2,002,470 | $1,269,403 | $231,564 | $205,360 |
| Goodwill | $49,697 | $49,697 | $49,697 | $49,697 |
| Net PPE | $11,779,468 | $12,399,298 | $13,492,452 | $2,929,856 |
| Accumulated Depreciation | $-2,117,842 | $-1,275,030 | $-957,255 | $-877,823 |
| Gross PPE | $13,897,310 | $13,674,328 | $14,449,707 | $3,807,679 |
| Leases | $3,861 | $3,405 | $3,639 | $502,882 |
| Construction In Progress | $600,000 | $2,000,020 | $2,000,020 | $0 |
| Other Properties | $600,610 | $709,773 | $1,160,342 | $1,112,831 |
| Machinery Furniture Equipment | $3,622,844 | $3,111,918 | $2,946,725 | $2,191,966 |
| Buildings And Improvements | $5,302,616 | $4,526,432 | $4,787,963 | $0 |
| Land And Improvements | $3,767,379 | $3,322,780 | $3,551,018 | $0 |
| Properties | $0 | $0 | $0 | $0 |
| Duefrom Related Parties Current | $2,443,975 | $1,230,308 | $1,099,098 | $2,710,301 |
| Other Short Term Investments | $46,158 | $21,148 | $20,075 | $14,881 |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-8,600,432 | $-8,984,277 | $-24,803,758 | $-15,253,712 |
| Operating Activities | ||||
| Operating Cash Flow | $-8,447,614 | $-7,717,034 | $-15,635,999 | $-14,870,639 |
| Cash Flow From Continuing Operating Activities | $-8,447,614 | $-7,717,034 | $-15,635,999 | $-14,870,639 |
| Operating Gains Losses | $-1,593,629 | - | $-1,914,351 | $-856,637 |
| Investing Activities | ||||
| Capital Expenditure | $-152,818 | $-1,267,243 | $-9,167,759 | $-383,073 |
| Investing Cash Flow | $-2,014,855 | $-798,269 | $-13,760,357 | $-21,497 |
| Cash Flow From Continuing Investing Activities | $-2,014,855 | $-798,269 | $-13,760,357 | $-21,497 |
| Net Other Investing Changes | $-1,862,037 | $468,974 | $637,995 | $351,474 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $5,417,396 | $649,039 | $10,000,017 | $41,275,573 |
| Financing Cash Flow | $14,056,091 | $5,046,684 | $12,694,007 | $35,048,288 |
| Cash Flow From Continuing Financing Activities | $14,056,091 | $5,046,684 | $12,694,006 | $35,048,288 |
| Net Other Financing Charges | $-1,830,470 | $-391,575 | $-717,887 | $-3,194,798 |
| Net Common Stock Issuance | $5,417,396 | $649,039 | $9,899,565 | $35,275,573 |
| Common Stock Issuance | $5,417,396 | $649,039 | $10,000,017 | $35,275,573 |
| Repurchase Of Capital Stock | - | $0 | $-100,452 | $0 |
| Net Preferred Stock Issuance | - | - | $0 | $6,000,000 |
| Preferred Stock Issuance | - | - | $0 | $6,000,000 |
| Other | ||||
| Repayment Of Debt | $-28,595,665 | $-26,276,786 | $-21,272,295 | $-40,390,159 |
| Issuance Of Debt | $39,064,830 | $26,825,029 | $21,250,883 | $26,531,672 |
| Interest Paid Supplemental Data | $947,139 | $704,839 | $406,885 | $588,051 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $3,459,893 | $315,105 | $3,833,195 | $20,749,683 |
| Beginning Cash Position | $315,105 | $3,833,195 | $20,749,683 | $286,487 |
| Effect Of Exchange Rate Changes | $-448,834 | $-49,471 | $-214,139 | $307,044 |
| Changes In Cash | $3,593,622 | $-3,468,619 | $-16,702,349 | $20,156,152 |
| Proceeds From Stock Option Exercised | $0 | $4,240,977 | $3,533,741 | $10,826,000 |
| Net Issuance Payments Of Debt | $10,469,165 | $548,243 | $-21,412 | $-13,858,487 |
| Net Short Term Debt Issuance | $1,205,172 | $809,826 | $660,608 | $-1,240,944 |
| Short Term Debt Payments | $-26,703,876 | $-25,149,603 | $-19,532,735 | $-27,285,518 |
| Short Term Debt Issuance | $27,909,048 | $25,959,429 | $20,193,343 | $26,044,574 |
| Net Long Term Debt Issuance | $9,263,993 | $-261,583 | $-682,020 | $-12,617,543 |
| Long Term Debt Payments | $-1,891,789 | $-1,127,183 | $-1,739,560 | $-13,104,641 |
| Long Term Debt Issuance | $11,155,782 | $865,600 | $1,057,540 | $487,098 |
| Net Intangibles Purchase And Sale | $-97,143 | $-849,168 | $-6,189,564 | $-308,866 |
| Purchase Of Intangibles | $-97,143 | $-849,168 | $-6,189,564 | $-308,866 |
| Net PPE Purchase And Sale | $-55,675 | $-418,075 | $-2,978,195 | $-61,471 |
| Purchase Of PPE | $-55,675 | $-418,075 | $-2,978,195 | $-74,207 |
| Change In Working Capital | $-777,930 | $159,681 | $-7,898,737 | $-8,692,762 |
| Change In Other Current Liabilities | $2,042,077 | $177,964 | $-1,960,571 | $806,812 |
| Change In Payables And Accrued Expense | $5,013,066 | $1,115,619 | $472,146 | $-285,992 |
| Change In Accrued Expense | $545,030 | $69,070 | $-115,668 | $-913,280 |
| Change In Interest Payable | $545,030 | $69,070 | $-115,668 | $-913,280 |
| Change In Payable | $4,468,036 | $1,046,549 | $587,814 | $627,288 |
| Change In Account Payable | $4,468,036 | $1,046,549 | $716,615 | $1,734,423 |
| Change In Prepaid Assets | $-893,290 | $-2,511,461 | $-1,493,041 | $-1,270,204 |
| Change In Inventory | $-829,975 | $146,451 | $-890,903 | $-485,469 |
| Change In Receivables | $-6,109,808 | $1,231,108 | $-4,026,368 | $-7,457,909 |
| Changes In Account Receivables | $-6,109,808 | $1,231,108 | $-4,026,368 | $-3,244,181 |
| Other Non Cash Items | $3,340,817 | $288,831 | $-975,747 | $1,895,479 |
| Stock Based Compensation | $2,312,241 | $1,689,712 | $577,931 | $24,401 |
| Unrealized Gain Loss On Investment Securities | $-21,368 | $-2,470 | $-4,584 | $-1,676 |
| Asset Impairment Charge | $6,045,178 | $5,092,835 | $11,850,788 | $5,621,938 |
| Deferred Tax | $22,722 | $-11,843 | $656,978 | $780,099 |
| Deferred Income Tax | $22,722 | $-11,843 | $656,978 | $780,099 |
| Depreciation Amortization Depletion | $1,369,353 | $1,249,238 | $614,377 | $188,890 |
| Depreciation And Amortization | $1,369,353 | $1,249,238 | $614,377 | $188,890 |
| Depreciation | $1,369,353 | $1,249,238 | $614,377 | $188,890 |
| Gain Loss On Investment Securities | $-1,525,020 | - | $-3,384 | $20,257 |
| Net Income From Continuing Operations | $-19,144,998 | $-16,183,018 | $-18,542,654 | $-13,830,371 |
| Common Stock Payments | - | $0 | $-100,452 | $0 |
| Net Business Purchase And Sale | - | $0 | $-5,230,593 | $0 |
| Purchase Of Business | - | $0 | $-5,230,593 | $0 |
| Change In Tax Payable | - | $0 | $-128,801 | $-1,107,135 |
| Change In Income Tax Payable | - | $0 | $-128,801 | $-1,107,135 |
| Net Investment Purchase And Sale | - | - | $0 | $-2,634 |
| Purchase Of Investment | - | - | $0 | $-2,634 |
| Sale Of PPE | - | - | $0 | $12,736 |
| Change In Other Current Assets | - | - | - | $0 |
Fetched: 2026-06-17